04 June 2026
Oxford Nanopore Technologies plc
(the "Company")
Results of Annual General Meeting
The Annual General Meeting of the Company was held earlier today. All resolutions, as set out in the Company's Notice of Annual General Meeting dated 1 May 2026, were passed by the appropriate majority on a poll. Details of the poll results are set out below.
Oxford Nanopore Technologies plc Annual General Meeting Poll Results:
|
No. |
RESOLUTION |
VOTES |
% |
VOTES |
% |
VOTES |
% of ISC VOTED |
VOTES |
|
1. |
To receive and consider the Directors' report, the Audited Statement of Accounts and Auditor's Report of the Company for the financial year ended 31 December 2025 |
644,479,235 |
99.99% |
53,609 |
0.01% |
644,532,844 |
66.25% |
5,809,438 |
|
2. |
To receive and approve the Directors' Remuneration Report for the year ended 31 December 2025 |
635,703,914 |
98.61% |
8,979,992 |
1.39% |
644,683,906 |
66.26% |
5,658,376 |
|
3. |
To elect Francis Van Parys as a director of the Company |
644,496,369 |
99.95% |
346,047 |
0.05% |
644,842,416 |
66.28% |
5,499,866 |
|
4. |
To re-elect Dr Sarah Fortune as a director of the Company |
642,145,731 |
98.77% |
8,001,129 |
1.23% |
650,146,860 |
66.82% |
195,422 |
|
5. |
To re-elect Adrian Hennah as a director of the Company |
641,793,032 |
98.72% |
8,342,451 |
1.28% |
650,135,483 |
66.82% |
206,799 |
|
6. |
To re-elect Nicholas Keher as a director of the Company |
644,012,773 |
99.05% |
6,193,516 |
0.95% |
650,206,289 |
66.83% |
135,993 |
|
7. |
To re-elect Dr Daniel Mahony as a director of the Company |
642,158,034 |
99.60% |
2,599,012 |
0.40% |
644,757,046 |
66.27% |
5,585,236 |
|
8. |
To re-elect John O'Higgins as a director of the Company |
641,833,262 |
99.55% |
2,923,769 |
0.45% |
644,757,031 |
66.27% |
5,585,251 |
|
9. |
To re-elect Dr Heather Preston as a director of the Company |
641,939,772 |
98.74% |
8,206,188 |
1.26% |
650,145,960 |
66.82% |
196,322 |
|
10. |
To re-elect Katherine (Kate) Priestman as a director of the Company |
642,128,939 |
98.77% |
8,017,121 |
1.23% |
650,146,060 |
66.82% |
196,222 |
|
11. |
To re-elect Duncan Tatton-Brown as a director of the Company |
615,129,122 |
94.62% |
34,986,815 |
5.38% |
650,115,937 |
66.82% |
226,345 |
|
12. |
To appoint Deloitte LLP as auditors of the Company |
638,710,166 |
99.10% |
5,822,215 |
0.90% |
644,532,381 |
66.25% |
5,809,901 |
|
13. |
To authorise the Audit & Risk Committee to determine the remuneration of the auditors |
639,055,685 |
99.11% |
5,769,712 |
0.89% |
644,825,397 |
66.28% |
5,516,885 |
|
14. |
To authorise the board of directors to allot shares |
622,831,323 |
96.59% |
21,984,854 |
3.41% |
644,816,177 |
66.28% |
5,526,105 |
|
15. |
To disapply pre-emption rights* |
625,847,515 |
97.07% |
18,881,645 |
2.93% |
644,729,160 |
66.27% |
5,613,122 |
|
16. |
To further disapply pre-emption rights* |
620,910,261 |
96.31% |
23,811,090 |
3.69% |
644,721,351 |
66.27% |
5,620,931 |
|
17. |
To authorise the Company to make market purchases* |
644,443,311 |
99.94% |
368,535 |
0.06% |
644,811,846 |
66.28% |
5,530,436 |
|
18. |
To authorise the Company to hold any general meeting (other than an Annual General Meeting) on not less than 14 clear days' notice* |
631,898,194 |
97.99% |
12,938,231 |
2.01% |
644,836,425 |
66.28% |
5,505,857 |
|
19. |
To authorise UK political expenditure not exceeding £100,000 |
642,283,505 |
99.77% |
1,512,176 |
0.23% |
643,795,681 |
66.17% |
6,546,601 |
* Special Resolution
NOTES:
1. Votes "For" and "Against" are expressed as a percentage of votes received.
2. The total number of ordinary shares in issue and eligible to be voted on at the AGM was 972,930,353.
3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" any resolution nor in the calculation of the proportion of "Total issued share capital voted" for any resolution.
4. The Board appreciates the support shown by shareholders for the resolutions at today's AGM.
In accordance with Listing Rule 9.6.2, a copy of the resolutions will shortly be submitted to the National Storage Mechanism and will be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
A copy of the poll results for the AGM will also be available shortly on the Company's website at https://nanoporetech.com/about-us/investors/shareholder-information.
-ENDS-
For further information please contact:
About Oxford Nanopore Technologies plc:
Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer. Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture. Oxford Nanopore Technologies products are for Research Use Only (RUO). Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in‐vitro diagnostic devices in some jurisdictions, please check individual product labelling. For more information, please visit: https://nanoporetech.com/